Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target

Annals of the New York Academy of Sciences

Volumn 1030, Issue , 2004, Pages 150-157

  Miyata, Yoshihiko ^a   Nishida, Eisuke ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cancer therapy; Cdc37; CK2; Hsp90; Molecular chaperone; Protein kinase

Indexed keywords

CELL CYCLE PROTEIN 37; CYCLIN DEPENDENT KINASE 2; PROTEIN KINASE; SERINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CONFERENCE PAPER; GENE MUTATION; NONHUMAN; POSITIVE FEEDBACK; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE;

ANIMALIA; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 15044362465     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1329.019     Document Type: Conference Paper

References (37)

1. SCHWARTZBERG, P.L. 1998. The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene 17: 1463-1468.
2. PEARSON, G., F. ROBINSON, T. BEERS GIBSON, et al. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22: 153-183.
3. FRANKE, T.F., C.P. HORNIK, L. SEGEV, et al. 2003. P13K/Akt and apoptosis: size matters. Oncogene 22: 8983-8998.
4. NURSE, P. 2002. Cyclin dependent kinases and cell cycle control (Nobel Lecture). Chembiochem 3: 596-603.
5. CARMENA, M. & W.C. EARNSHAW. 2003. The cellular geography of aurora kinases. Nat. Rev. Mol. Cell Biol. 4: 842-854.
6. LITCHFIELD, D.W. 2003. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369: 1-15.
7. MEGGIO, F. & L.A. PINNA. 2003. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17: 349-368.
8. PINNA, L.A. 2003. The raison d'etre of constitutively active protein kinase: the lesson of CK2. Acc. Chem. Res. 36: 378-384.
9. XU, X., E. LANDESMAN-BOLLAG, P.L. CHANNAVAJHALA & D.C. SELDIN. 1999. Murine protein kinase CK2: gene and oncogene. Mol. Cell. Biochem. 191: 65-74.
10. SELDIN, D.C. & P. LEDER. 1995. Casein kinase 11 α transgene-induced murine lymphoma: relation to theileriosis in cattle. Science 267: 894-897.
11. REED, S.I. 1980. The selection of S. cerevisiae mutants defective in the start event of cell division. Genetics 95: 561-577.
12. CUTFORTH, T. & G.M. RUBIN. 1994. Mutations in Hsp83 and cdc37 impair signaling by the sevenless receptor tyrosine kinase in Drosophila. Cell 77: 1027-1036.
13. v-scr activity in yeast. Mol. Biol. Cell 7: 1405-1417.
14. 1 and mitotic cyclins. Proc. Natl. Acad. Sci. USA 92: 4651-4655.
15. v-src protein kinases is a mammalian homolog of the cell cycle control protein cdc37. Biochemistry 36: 3600-3607.
16. HUNTER, T. & R.Y.C. POON. 1997. Cdc37: a protein kinase chaperone? Trends Cell Biol. 7: 157-161.
17. MACLEAN, M. & D. PICARD. 2003. Cdc37 goes beyond Hsp90 and kinases. Cell Stress Chaperones 8: 114-119.
18. CSERMELY, P., T. SCHNAIDER, C. SOTI, et al. 1998. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol. Ther. 79: 129-168.
19. YAHARA, I., Y. MINAMI & Y. MIYATA. 1998. The 90-kDa stress protein, Hsp90, is a novel molecular chaperone. Ann. N.Y. Acad. Sci. 851: 54-60.
20. PRATT, W.B. & D.O. TOFT. 2003. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. 228: 111-133.
21. Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 10: 1491-1502.
22. KIMURA. Y., S.L. RUTHERFORD, Y. MIYATA, et al. 1997. Cdc37 is a molecular chaperone with specific functions in signal transduction. Genes Dev. 11: 1775-1785.
23. STEPANOVA, L., G. YANG, F. DEMAYO, et al. 2000. Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia. Oncogene 27: 2186-2193.
24. STEPANOVA, L., M. FINEGOLD, F. DEMAYO, et al. 2000. The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues. Mol. Cell. Biol. 20: 4462-4473.
25. ROE, S.M., M.M. ALI, P. MEYER, et al. 2004. The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell 116: 87-98.
26. FLISS, A.E., Y. FANG, F. BOSCHELLI & A.J. CAPLAN. 1997. Differential in vivo regulation of steroid hormone receptor activation by Cdc37p. Mol. Biol. Cell 8: 2501-2509.
27. BANDHAKAVI, S., R.O. McCANN, D.E. HANNA & C.V.C. GLOVER. 2003. A positive feedback loop between protein kinase CKII and Cdc37 promotes the activity of multiple protein kinases. J. Biol. Chem. 278: 2829-2836.
28. SHAO, J., T. PRINCE, S.D. HARTSON & R.L. MATTS. 2003. Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37. J. Biol. Chem. 278: 38117-38120.
29. MIYATA, Y. & E. NISHIDA. 2004. CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone Cdc37. Mol. Cell. Biol. 24: 4065-4074.
30. ABBAS-TERKI, T., O. DONZE & D. PICARD. 2000. The molecular chaperone Cdc37 is required for Stell function and pheromone-induced cell cycle arrest. FEBS Lett. 467: 111-116.
31. MIYATA, Y. & I. YAHARA. 1992. The 90-kDa heat shock protein, HSP90, binds and protects casein kinase 11 from self-aggregation and enhances its kinase activity. J. Biol. Chem. 267: 7042-7047.
32. YARDEN, Y. & M.X. SLIWKOWSKI. 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2: 127-137.
33. DRUKER, B.J. 2002. Perspectives on the development of a molecularly targeted agent. Cancer Cell 1: 31-36.
34. MALONEY, A. & P. WORKMAN. 2002. HSP90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opin. Biol. Ther. 2: 3-24.
35. ISAACS, J.S., W. XU & L. NECKERS. 2003. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3: 213-217.
36. SARNO, S., S. Moro, F. Meggio, et al. 2002. Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol. Ther. 93: 159-168.
37. RUZZENE, M., D. PENZO & L.A. PINNA. 2002. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. Biochem. J. 364: 41-47.